PharmaDoctor and Star enter into a strategic partnership
PharmaDoctor (owned by Escripts Marketing Ltd), and Star (part of the Uniphar Group), are pleased to announce a strategic partnership between the two companies...
Novo Nordisk acquires Ziylo to accelerate glucose responsive insulin
Ziylo and Novo Nordisk have announced that Novo Nordisk has acquired all of the shares of Ziylo, a University of Bristol spin-out company based...
Syneos Health acquires advisory & operational solutions provider Kinapse
Syneos Health, Inc. a biopharmaceutical solutions organisation, has announced the acquisition of Kinapse, a market leading advisory and operational solutions provider to the global...
Almirall acquires US medical dermatology portfolio from Allergan
Almirall, S.A. (ALM) has announced the acquisition of a portfolio of five products from Allergan’s Medical Dermatology unit in the United States for $500...
UDG Healthcare acquire Create NYC and SmartAnalyst
UDG Healthcare plc, an international healthcare services provider, is pleased to announce the acquisition of Create NYC, a New York-based disruptive creative communications agency...
Laekna acquires worldwide rights to two oncology assets
Laekna Inc., a biotechnology company headquartered in Shanghai, announced the signing of an agreement with Novartis Pharma for exclusive global rights to develop and...
LEO Pharma to acquire Bayer’s dermatology unit
LEO Pharma has entered into a definitive agreement to buy Bayer's global prescription dermatology unit. The portfolio to be acquired includes branded topical prescription...
AstraZeneca sells rights for Atacand to Cheplapharm
AstraZeneca has agreed to sell the commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (fixed-dose combination of candesartan cilexetil and hydrochlorothiazide) in Europe...
NanoGenics acquired to advance gene therapy
The Scottish Biotech company Ryboquin, announces the acquisition of Nanogenic Solutions, to form a new product and platform company, Nanogenics Limited. The combined company,...
EUSA Pharma announce acquisition of SYLVANT® from Janssen
EUSA Pharma acquires SYLVANT from Janssen for $115 million
Latest articles
Changes to GSK sales representative incentive programme
GSK has announced changes to its sales representative incentive programme for representatives in certain countries. These changes reflect the growing shift in GSK’s portfolio...
Peer-to-peer mental health support app goes live
The UK's first free peer-to-peer mental health support app, 'Unmasked', has gone live after a period of extensive testing. The brainchild of three Yorkshiremen, Logan...
Drug firms accused of illegal market sharing over anti-nausea tablets
The Competitions and Markets Authority (CMA) has accused four pharmaceutical companies of illegal market sharing over anti-nausea tablets. The CMA has provisionally found that the pharmaceutical...
Popular articles
Peer-to-peer mental health support app goes live
The UK's first free peer-to-peer mental health support app, 'Unmasked', has gone live after a period of extensive testing. The brainchild of three Yorkshiremen, Logan...
NICE issues final guidance for Tegsedi ®▼
Akcea Therapeutics UK Ltd, an affiliate of Akcea Therapeutics, Inc announced that the National Institute for Health and Care Excellence (NICE) has published its...
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Changes to GSK sales representative incentive programme
GSK has announced changes to its sales representative incentive programme for representatives in certain countries. These changes reflect the growing shift in GSK’s portfolio...
Wasdell Group expands portfolio with Honeywood acquisition
The Wasdell Group (Wasdell), a leading outsourcing partner for companies in the pharmaceutical industry, has announced its acquisition of Honeywood Limited, a specialist manufacturer...